| Miss Emily Panyard, MA CF-SLP | |
|
1200 1st St Ne Fl 8, Washington, DC 20002-3361 | |
| (202) 442-4800 | |
| Not Available |
| Full Name | Miss Emily Panyard |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1200 1st St Ne Fl 8, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215616792 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLPCF2000083 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Emily Panyard, MA CF-SLP 1200 1st St Ne Fl 8, Washington, DC 20002-3361 Ph: () - | Miss Emily Panyard, MA CF-SLP 1200 1st St Ne Fl 8, Washington, DC 20002-3361 Ph: (202) 442-4800 |
News Archive
According to two new studies, "giving pregnant and nursing women triple antiretroviral drug therapy, or treating breast-fed infants with an antiretroviral medication, can dramatically cut transmission rates, enabling moms to both breast-feed and to protect nearly all children from infection," HealthDay News/Bloomberg Businessweek reports (Goodwin, 6/16).
CIGNA International announced it will develop and offer individual Private Medical Insurance (PMI) to respond to the emerging needs of customers around the globe. CIGNA International – a world leader in global life, accident and health insurance and global expatriate benefits – will provide local PMI for citizens in countries outside the United States as well as to individual expatriates and high net worth individuals.
According to World Health Organization researchers there is a rise in Australia in the number of seasonal influenza cases resistant to Tamiflu, the most commonly used antiviral drug. The rise in such cases involving the pandemic 2009 A (H1N1) flu strain, also known as swine flu, took place during Australia's most recent winter: May through August of 2011.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 3 days ago
Sheryl Jacob Desbordes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-4424 | |
Karen Garrido-nag, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Speech, Language And Hearing Sciences, Washington, DC 20002 Phone: 202-448-6964 Fax: 202-448-5324 | |
Voicetrainer, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Pennsylvania Ave Nw, Suite 300, Washington, DC 20006 Phone: 202-580-6646 Fax: 202-580-6559 | |
Samantha Wasilus, M.S CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Macarthur Blvd Nw, Washington, DC 20007 Phone: 202-333-1403 Fax: 202-333-1404 | |
Tahera Sparks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Connecticut Ave Nw # 100, Washington, DC 20008 Phone: 202-525-1641 | |
Sydney Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Massachusetts Ave Ne Ste C9, Washington, DC 20002 Phone: 202-544-5469 | |
Joyce Doyle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 5th St Se, Washington, DC 20032 Phone: 571-221-2840 |